Curing gastric cancer - hone the scalpel with magic?
1996

Curing Gastric Cancer: A New Approach

Sample size: 112 Editorial Evidence: moderate

Author Information

Author(s): A Webb, D Cunningham

Primary Institution: The Royal Marsden Hospital and The Institute of Cancer Research

Hypothesis

Can adjuvant chemotherapy improve survival rates in gastric cancer patients?

Conclusion

Adjuvant chemotherapy may improve outcomes for gastric cancer patients, but it is not yet standard treatment.

Supporting Evidence

  • Only about 20% of gastric cancer patients present with surgically curable disease.
  • 5-year survival rates for stage I, II, and III gastric cancer are 72%, 32%, and 10%, respectively.
  • Adjuvant chemotherapy has shown a significant improvement in 3-year survival for certain treatments.

Takeaway

Doctors are trying new medicines to help people with stomach cancer live longer after surgery. Some treatments are showing promise, but more research is needed.

Methodology

The study involved a prospective randomized trial comparing chemotherapy with surgery alone in node-positive gastric cancer patients.

Limitations

The study is relatively small and may not provide definitive evidence of survival benefits.

Participant Demographics

Patients with node-positive gastric cancer.

Statistical Information

P-Value

0.0009

Confidence Interval

95% confidence interval 0.68-0.98

Statistical Significance

p=0.0009

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication